Applications are open
Apply Today
The causes driving the opioid crisis are more complex than just the actions of pharmaceutical companies. A fragmented health care system, ineffective policies, and current federal and state laws are all contributing to the level of difficulty when it comes to combating overdoses and addiction within the United States.
Making medications more affordable would improve the health of the most vulnerable among us. In some circumstances, it could even reduce total health care spending by averting preventable hospitalizations and emergency room visits.
A no-deal Brexit would make it harder for the United Kingdom to recruit health workers into their system, will jeopardize continuing care for British citizens with pre-existing conditions living outside the U.K., and could even lead to an increase in cardiovascular disease-related deaths, say researchers.
Out-of-pocket expenses for prescription medications impose a heavy financial burden, especially on low- and middle-income patients with chronic diseases, often reducing adherence to medication and worsening health outcomes. Members of Congress have launched an investigation into the rising prices of life-saving drugs like insulin.
Hospitals in Michigan and across the country rang in the New Year with a federal mandate to reveal their once-secret master price lists, although it's unclear whether this new requirement will assist many patients or contain ever-rising health care costs.
In an article from the Detroit Free Press, Assistant Professor Paul Fleming gives his thoughts on how the Trump administration's proposed rule change towards immigrant access of government benefits and services could effect health outcomes.